Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Watanabe

Showing results (791-800 of 817) with videos related to

Pageof 82
Sort By:
Cancer Science|May 4, 2023
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trialKazutaka Fujita, Ryo Arai, Satoshi Shoji, et al.
Scientific Reports|March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancerDaichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
Cells|November 6, 2020
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma PatientsRiuko Ohashi, Hajime Umezu, Ayako Sato, et al.
Nature Communications|October 29, 2017
Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergeticsTakaaki Akaike, Tomoaki Ida, Fan-Yan Wei, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Influenza A infection accelerates disease-associated microglia formation during physiological agingRogan A Grant, Constance E Runyan, Grace A Minogue, et al.
Translational Lung Cancer Research|August 25, 2021
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung diseaseYusuke Sato, Satoshi Watanabe, Takeshi Ota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant CancersYuki Katayama, Tadaaki Yamada, Keiko Tanimura, et al.
Frontiers in Oncology|October 11, 2021
The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody <i>via</i> Continuation or Rechallenge After the Occurrence of Immune-Related Adverse EventsToshiya Fujisaki, Satoshi Watanabe, Takeshi Ota, et al.
Ebiomedicine|July 7, 2020
Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 studyTatsuro Fukuhara, Haruhiro Saito, Naoki Furuya, et al.
Heart (British Cardiac Society)|November 21, 2018
Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysisRita Pavasini, Matteo Serenelli, Carlos A Celis-Morales, et al.
Pageof 82

Showing results (791-800 of 817) with videos related to

Sort By:
Pageof 82
Cancer Science|May 4, 2023
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trialKazutaka Fujita, Ryo Arai, Satoshi Shoji, et al.
Scientific Reports|March 6, 2023
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancerDaichi Fujimoto, Satoru Miura, Keisuke Tomii, et al.
Cells|November 6, 2020
Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma PatientsRiuko Ohashi, Hajime Umezu, Ayako Sato, et al.
Nature Communications|October 29, 2017
Cysteinyl-tRNA synthetase governs cysteine polysulfidation and mitochondrial bioenergeticsTakaaki Akaike, Tomoaki Ida, Fan-Yan Wei, et al.
Biorxiv : the Preprint Server for Biology|December 19, 2025
Influenza A infection accelerates disease-associated microglia formation during physiological agingRogan A Grant, Constance E Runyan, Grace A Minogue, et al.
Translational Lung Cancer Research|August 25, 2021
Subsequent systemic therapy for non-small cell lung cancer patients with immune checkpoint inhibitor-related interstitial lung diseaseYusuke Sato, Satoshi Watanabe, Takeshi Ota, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 4, 2024
YAP Regulates HER3 Signaling-Driven Adaptive Resistance to RET Inhibitors in RET-Aberrant CancersYuki Katayama, Tadaaki Yamada, Keiko Tanimura, et al.
Frontiers in Oncology|October 11, 2021
The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody <i>via</i> Continuation or Rechallenge After the Occurrence of Immune-Related Adverse EventsToshiya Fujisaki, Satoshi Watanabe, Takeshi Ota, et al.
Ebiomedicine|July 7, 2020
Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 studyTatsuro Fukuhara, Haruhiro Saito, Naoki Furuya, et al.
Heart (British Cardiac Society)|November 21, 2018
Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysisRita Pavasini, Matteo Serenelli, Carlos A Celis-Morales, et al.
Pageof 82